JPRN-UMIN000001147
Unknown
未知
The clinical study for research into genetic factors whether adult patients with asthma can achieve to be clinical remission or not - The clinical study for research into genetic factors whether adult patients with asthma can achieve to be clinical remission or not
ational Hospital Organization Sagamihara National Hospital0 sites200 target enrollmentMay 3, 2008
Conditionsbronchial asthma
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- bronchial asthma
- Sponsor
- ational Hospital Organization Sagamihara National Hospital
- Enrollment
- 200
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •adult patients with asthma without exacerbation less than 30 months after withdrawing all therapy.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of the effect of the genetic polymorphism of drug metabolizing enzyme/transporter and drug interaction on the pharmacokinetics and pharmacodynamics of clopidogrelNot ApplicableKCT0000429Seoul National University18
Completed
Phase 4
Vitamin D supplementation reduces serum uric acid concentration in patients with prediabetes and hyperuricaemia-a reduction in serum uric acid concentration in patients with prediabetes and hyperuricaemiaTCTR20200219002The National Science and Technology Development Agency of Thailand71
Completed
Not Applicable
A research that investigates the genetic factors for the idiopathic pulmonary pneumonias (IIPs) with the subjects that have been enrolled in the multi-institutional observational study for the IIPs, NEJ030.Idiopathic pulmonary pneumoniaJPRN-UMIN000032117Jichi Medical University400
Completed
Not Applicable
Studies on the genetic abnormality and therapeutic effects and prognosis of multiple myelomaMultiple myelomaJPRN-UMIN000017005Clinical Hematlogy Study Group of National Hospital Organization (CHSGONHO)85
Completed
Not Applicable
Clinical study to investigate the characteristics of symptom recurrence after discontinuing treatment compared to continuation of treatment in patients with Irritable Bowel Syndrome with constipation (C-IBS) who responded favorably to treatment with tegaserod, a partial agonist of the 5-HT4 receptor-K589 Irritable bowel syndrome without diarrhoeaIrritable bowel syndrome without diarrhoeaK589PER-016-01OVARTIS BIOSCIENSES PERU S.A.,